Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (7): 736-739.

Previous Articles     Next Articles

Effects of asiatic acid as a novel glycogen phosphorylase inhibitor on glucose metabolism

LIU Jun1, MAO Li-fei1, SHANG Jing1, SUN Hong-bin2, ZHANG Lu-yong1   

  1. 1New Drug Screening Center, China Pharmaceutical University,
    2Center of Drug Discovery, China Pharmaceutical University,Nanjing 210009,Jiangsu,China
  • Received:2011-04-06 Revised:2011-07-06 Online:2011-07-26 Published:2011-09-22

Abstract: AIM: To determine the effects of asiatic acid, a novel glycogen phosphorylase inhibitor, on glucose consumption in HepG2 cell and on blood glucose and hepatic glycogen in mice,and study the hypoglycemic mechanism.METHODS: Mice were given intragastrically either vehicle or asiatic acid for 7 days.The model of hyperglycemia in mice was induced by subcutaneous injection of Adrenaline; the fasting plasma glucose and hepatic glycogen of mice were measured.RESULTS: The elevation of blood glucose level caused by Adrenaline was antagonized by asiatic acid significantly. Asiatic acid also increased the hepatic glycogen content in adrenaline-induced hyperglycemia mice.Furthermore,Asiatic acid showed significant effect on glucose consumption in HepG2 cells, and its IC50 of inhibiting glycogen phosphorylase was 12.1 μmol/L in vivo.CONCLUSION: Asiatic acid presents anti-diabetic effect, the mechanism is probably concerned with inhibiting excessive hepatic glycogen degradation.

Key words: Asiatic acid, Glycogen phosphorylase, Adrenaline, Hepatic glycogen, Hypoglycemic effect

CLC Number: